SANTA CLARA, Calif.--(BUSINESS WIRE)--ServiceNow® (NYSE: NOW), the enterprise IT cloud company, today announced that UK-headquartered AstraZeneca has implemented ServiceNow software-as-a-service to evolve how IT services are delivered to its global enterprise users.
AstraZeneca, an innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of medicines, consolidated its global IT service management capability on ServiceNow. The company has extended the IT service model into critical lines of business including finance with a view toward an extension into facilities. This new capability provides users with an intuitive, consumerized self-service experience. From project kickoff to deployment, this transformation was achieved in four months.
AstraZeneca has identified the opportunity to link service management capability across the company’s IT functions with the goal of creating a unified shared services organization. ServiceNow enables the company to standardize IT service delivery globally and automate manual processes. Transforming the end-user experience will significantly improve the IT organization’s efficiency and responsiveness while reducing costs. AstraZeneca has introduced new self-service capabilities now available to its 51,500 employees and a number of IT partners built on the ServiceNow IT Service Automation suite.
“With ServiceNow, IT has a single system of record to manage requests and resolve issues for employees globally and to drive a self-service model for faster and easier interactions with IT online,” said Dave Smoley, CIO, AstraZeneca. “Automating IT service management processes enables the team to be more flexible and responsive.”
To extend its shared services capabilities, AstraZeneca built a custom application on ServiceNow to support finance request management and fulfillment. Questions relating to finance issues including invoice status are now captured, managed, processed and resolved within ServiceNow.
With ServiceNow Discovery operational, AstraZeneca plans to implement ServiceNow Orchestration to automate application and service provisioning. ServiceNow Performance Analytics and enhanced reporting will provide senior management access to actionable insights to monitor and quickly adapt service delivery strategies.
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com
ServiceNow is the enterprise IT cloud company. We transform IT by automating and managing IT service relationships across the global enterprise. Organizations deploy our service to create a single system of record for IT and automate manual tasks, standardize processes and consolidate legacy systems. Using our extensible platform, our customers create custom applications and evolve the IT service model to service domains inside and outside the enterprise. ServiceNow transforms IT from the department of no to the department of now. For more information, visit www.servicenow.com.
ServiceNow and the ServiceNow logo are registered trademarks of ServiceNow. All other brand and product names are trademarks or registered trademarks of their respective holders.